Dr. Jack West

More Great Videos on Targeted Therapies for Lung Cancer

March 1st, 2013 - by Dr. Jack West

We’ve been producing video content from the IASLC Targeted Therapies in Lung Cancer conference as quickly as we can. Here are a bunch of additional videos from a range of great experts all around the US, covering many of the most timely topics in targeted therapies for lung cancer today.

Dr. Heather Wakelee (Stanford) How Should We Use Molecular Marker Information in Earlier Stage NSCLC?

Dr. Karen Kelly (Univ. of California, Davis): What Molecular Markers Do You Routinely Send for in Your Patients with Advanced Non-Small Cell Lung Cancer?

Dr. Sarah Goldberg (Yale): How Do You Discuss the Pros and Cons of Molecular Testing, with Potential Delays and Need for Rebiopsy?

Drs. Ross Camidge (Univ. of Colorado) and Corey Langer (Univ. of Pennsylvania): Who Do You Recommend Repeat Biopsy for if There Isn’t Enough Tissue for Molecular Testing?

Dr. Bob Doebele (Univ. of Colorado): Will We Be Able to Use Molecular Markers and Apply Targeted Therapies to Broader Lung Cancer Subtypes in the Near Future?

I’ll have more to share again very soon. I hope these are helpful.  Interestingly, you’ll come to see the range of recommendations on the same question, even among experts.  This should highlight that there really isn’t only one right answer to these questions right now.

 

Share this:

Tags: , , ,

Comments are closed.